EU Trails FDA In Device Cybersecurity Guidance, But Harmonization Anticipated
This article was originally published in The Gray Sheet
Executive Summary
Story and podcast: Even though US regulators have provided more specific guidance on medical device cybersecurity requirements, European Union policy-makers appear to be on the same page, experts tell The Gray Sheet.
You may also be interested in...
FDA Says It Is Changing Its Cybersecurity Culture, And Others Should Too
Speaking at the 2015 mHealth Summit, Suzanne Schwartz, the FDA device center's top cybersecurity expert, said the agency is undergoing a cultural shift to better deal with device cybersecurity vulnerabilities and urged manufacturers, security researchers and hospitals to do the same.
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.